Literature DB >> 29110176

Avascular necrosis after long-term glucocorticoid treatment in MELAS: a cautionary note.

Han Som Choi1, Jae Hyun Lee1, Sun Ho Lee1, Young-Mock Lee2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29110176     DOI： 10.1007/s10545-017-0110-y

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  10 in total

Review 1.  Glucocorticoid-induced osteonecrosis.

Authors:  Robert S Weinstein
Journal:  Endocrine       Date:  2011-12-15       Impact factor: 3.633

2.  Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment.

Authors:  R P Ficat
Journal:  J Bone Joint Surg Br       Date:  1985-01

Review 3.  MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.

Authors:  Ayman W El-Hattab; Adekunle M Adesina; Jeremy Jones; Fernando Scaglia
Journal:  Mol Genet Metab       Date:  2015-06-15       Impact factor: 4.797

4.  Steroid responsive A3243G mutation MELAS: clinical and radiographic evidence for regional hyperperfusion leading to neuronal loss.

Authors:  Brian P Walcott; Brian L Edlow; Zongqi Xia; Kristopher T Kahle; Brian V Nahed; Jeremy D Schmahmann
Journal:  Neurologist       Date:  2012-05       Impact factor: 1.398

Review 5.  Management of mitochondrial stroke-like-episodes.

Authors:  J Finsterer
Journal:  Eur J Neurol       Date:  2009-09-23       Impact factor: 6.089

6.  Dynamic regulation of mitochondrial function by glucocorticoids.

Authors:  Jing Du; Yun Wang; Richard Hunter; Yanling Wei; Rayah Blumenthal; Cynthia Falke; Rushaniya Khairova; Rulun Zhou; Peixiong Yuan; Rodrigo Machado-Vieira; Bruce S McEwen; Husseini K Manji
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

7.  Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke-Like Episodes (MELAS): A Case Report and Critical Reappraisal of Treatment Options.

Authors:  Robert H Fryer; Jennifer M Bain; Darryl C De Vivo
Journal:  Pediatr Neurol       Date:  2015-12-19       Impact factor: 3.372

8.  Corticosteroid treatment of mitochondrial encephalomyopathies.

Authors:  Fabian H Rossi; Michael Okun; Anthony Yachnis; Ronald Quisling; William J Triggs
Journal:  Neurologist       Date:  2002-09       Impact factor: 1.398

Review 9.  Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.

Authors:  Sumit Parikh; Amy Goldstein; Amel Karaa; Mary Kay Koenig; Irina Anselm; Catherine Brunel-Guitton; John Christodoulou; Bruce H Cohen; David Dimmock; Gregory M Enns; Marni J Falk; Annette Feigenbaum; Richard E Frye; Jaya Ganesh; David Griesemer; Richard Haas; Rita Horvath; Mark Korson; Michael C Kruer; Michelangelo Mancuso; Shana McCormack; Marie Josee Raboisson; Tyler Reimschisel; Ramona Salvarinova; Russell P Saneto; Fernando Scaglia; John Shoffner; Peter W Stacpoole; Carolyn M Sue; Mark Tarnopolsky; Clara Van Karnebeek; Lynne A Wolfe; Zarazuela Zolkipli Cunningham; Shamima Rahman; Patrick F Chinnery
Journal:  Genet Med       Date:  2017-07-27       Impact factor: 8.822

Review 10.  Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.

Authors:  Sumit Parikh; Amy Goldstein; Mary Kay Koenig; Fernando Scaglia; Gregory M Enns; Russell Saneto; Irina Anselm; Bruce H Cohen; Marni J Falk; Carol Greene; Andrea L Gropman; Richard Haas; Michio Hirano; Phil Morgan; Katherine Sims; Mark Tarnopolsky; Johan L K Van Hove; Lynne Wolfe; Salvatore DiMauro
Journal:  Genet Med       Date:  2014-12-11       Impact factor: 8.822
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.